PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Recombinant Human Galectin-9 (carrier-free), 100 µg
Recombinant Human Galectin-9 (carrier-free), 25 µg
Recombinant Human Galectin-9 (E. coli expressed, carrier-free), 10 µg
Recombinant Human Galectin-9 (E. coli expressed, carrier-free), 100 µg
Recombinant Human Galectin-9 (E. coli expressed, carrier-free), 25 µg
Recombinant Human G-CSF (Animal-Free), 10 μg
Recombinant Human G-CSF (carrier-free), 10 μg
Recombinant Human G-CSF (carrier-free), 100 μg
Recombinant Human G-CSF (carrier-free), 25 μg
Recombinant Human GDF-3 (Animal-Free), 20 μg
Recombinant Human GDNF (Animal-Free), 10 μg
Recombinant Human GDNF (carrier-free), 10 µg
Recombinant Human GDNF (carrier-free), 2 µg
Recombinant Human GITR (TNFRSF18) Fc Chimera (carrier-free), 10 μg
Recombinant Human GITR (TNFRSF18) Fc Chimera (carrier-free), 25 μg
Recombinant Human Glypican-1 (carrier-free), 10 μg